Abstract:ObjectiveTo analyze the drug resistance of communityassociated methicillinresistant Staphylococcus aureus (CAMRSA) and healthcare associated MRSA(HAMRSA), so as to provide reference on empirical antimicrobial therapy for treating MRSA infection. MethodsMRSA isolated from clinical specimens from surgical department and intensive care unit (ICU) in a hospital between January 2006 and December 2008 were analyzed retrospectively , distribution and drug resistance of CAMRSA and HAMRSA were analysed statistically.ResultsEightseven strains were from ICU , the sources were as follows: 71 strains were from sputum, 6 from throat swabs, 5 from wound secretion, 2 from blood and venipuncture tubes respectively, and 1 from pleural effusion; HAMRSA accounted for 98.85%(86/87). Fortyone MRSA strains from surgical department were all isolated from wound pus, CAMRSA accounted for 48.75%(20/41) , and showed an increasing tendency year by year, which increased from 20.00% in 2006 to 71.43% in 2008 (χ2=8.24, 0.01<P<0.025). Antimicrobial susceptibility test results showed that the resistant rates of HAMRSA to clindamycin,tetracycline,erythromycin,ciprofloxacin,levofloxacin , and gentamycin was 98.13%,98.13%,100.00%, 100.00%,100.00% ,and 100.00% respectively, which was significantly higher than that of CAMRSA (which was 42.86%,66.70%,33.33%,0.00%,0.00% , and 4.76% respectively), there was significant difference between the two respectively(all P<0.005).ConclusionThere is an increasing tendency of CAMRSA infection in hospitalized patients , drug resistance of CAMRSA is different from that of HA MRSA , CAMRSA strains are usually susceptible to nonβlactam agents.